Aripiprazole (Abilify): Uses, Dosage, Side Effects & Long-Acting Injections

What Is Aripiprazole (Abilify)?

Aripiprazole, commonly known by its brand name Abilify, is an atypical antipsychotic medication used to treat various mental health conditions, including schizophrenia, bipolar disorder, major depressive disorder, and autism spectrum disorder. It works by modulating dopamine and serotonin activity in the brain, helping to stabilize mood and reduce symptoms of psychosis. For individuals in addiction recovery, aripiprazole is often prescribed to manage co-occurring mental health disorders that may have contributed to or developed alongside substance use.

How Aripiprazole Works in the Brain

Unlike first-generation antipsychotics, aripiprazole is a partial dopamine agonist. This means it doesn’t simply block dopamine. It acts as a “stabilizer,” reducing dopamine activity when levels are too high and increasing activity when levels are too low. This unique mechanism makes aripiprazole effective for a wide range of conditions and often results in a better side-effect profile compared to older medications. For people managing both addiction recovery and mental health conditions, this balanced approach can support long-term stability and reduce relapse risk.

Common Uses of Aripiprazole

• SchizophreniaReduces hallucinations, delusions, and disorganized thinking.
• Bipolar I DisorderTreats acute manic episodes and helps prevent mood cycles.
• Major Depressive DisorderUsed as an add-on treatment when antidepressants alone are insufficient.
• Autism Spectrum DisorderFDA-approved to reduce irritability and aggression in children and adolescents with autism.
• Anxiety and Co-Occurring ConditionsOften prescribed off-label to manage anxiety and agitation, particularly in dual-diagnosis cases where substance use disorder and mental illness coexist.

Dosage and Administration

Aripiprazole comes in multiple formulations to accommodate different patient needs and preferences:

Oral Forms

• TabletsAvailable in 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg strengths.
• Orally Disintegrating Tablets (ODT)Dissolve on the tongue; useful for patients who have difficulty swallowing or may be non-compliant with oral medication.
• Liquid Solution1 mg/mL concentration; helpful for dose adjustments and pediatric use.

Typical Dosing Range: Most adults begin with 10–15 mg daily, with adjustments based on clinical response and tolerance. Maintenance doses typically range from 10–30 mg daily. Dosing is individualized and must be determined by a healthcare provider.

Long-Acting Injectable Formulations

For patients struggling with medication adherence, a common challenge in addiction recovery, long-acting injectables (LAI) provide a significant advantage:

• Aripiprazole Monohydrate (Abilify Maintena)Monthly intramuscular injection administered every 26–30 days. Provides steady medication levels and eliminates the need for daily pills.
• Aripiprazole Extended-Release (Abilify Asimtufii)Extended-release subcutaneous injection given every month, designed for easier administration.
• Aripiprazole Lauroxil (Aristada)Ultra-long-acting formulation administered every 4 weeks or every 6 weeks, depending on the dose and formulation strength.

Long-acting injections are particularly valuable in substance abuse treatment settings because they support medication adherence, reduce the risk of relapse due to missed doses, and lower the risk of the medication being diverted or misused. Regular injections also reinforce accountability and engagement with the treatment program.

Serious Side Effects and Warnings

• Neuroleptic Malignant Syndrome (NMS)A rare but life-threatening condition characterized by high fever, muscle rigidity, altered mental status, and autonomic instability. Requires immediate medical attention.
• Tardive DyskinesiaLong-term use may cause involuntary repetitive movements, particularly in older adults. Risk is lower with aripiprazole than with first-generation antipsychotics but still present.
• Metabolic ChangesWeight gain, elevated blood sugar, and lipid abnormalities can occur. Regular monitoring is recommended, especially for patients with a family history of diabetes or heart disease.
• Orthostatic HypotensionBlood pressure may drop upon standing, causing dizziness or fainting, particularly when starting treatment.
• Increased Mortality in Elderly PatientsAntipsychotics, including aripiprazole, carry an FDA black-box warning for increased mortality risk in elderly patients with dementia-related psychosis.
• Seizure RiskMay lower seizure threshold; use with caution in patients with a history of seizures.
• QT ProlongationRare but serious; ECG monitoring may be warranted in high-risk patients.

Special Populations and Contraindications

Aripiprazole is not recommended for patients with:

• Allergies to aripiprazole or any component of the formulation
• Acute myocardial infarction or unstable cardiac conditions
• Uncontrolled hypertension
• Dementia-related psychosis (due to increased mortality risk)

Pregnant women should discuss risks and benefits with their healthcare provider, as aripiprazole crosses the placenta. Breastfeeding is not recommended due to excretion in breast milk. Adolescents and children require lower doses and careful monitoring for side effects, particularly weight gain and metabolic changes.

Drug Interactions

Aripiprazole can interact with several medications and substances:

• Alcohol and CNS DepressantsMay increase sedation and impair judgment. Critical for individuals in recovery to avoid alcohol entirely.
• CYP3A4 and CYP2D6 InhibitorsMedications like ketoconazole, fluoxetine, and paroxetine can increase aripiprazole levels, requiring dose reduction.
• CYP3A4 InducersMedications like carbamazepine and rifampin decrease aripiprazole levels, potentially reducing efficacy.
• Antihypertensive MedicationsMay have additive effects, lowering blood pressure excessively.

Always inform healthcare providers of all medications, supplements, and substances, especially important for individuals in addiction recovery who may be taking multiple prescribed medications or have a history of substance use.

Aripiprazole in Addiction Recovery

Dual diagnosis, the coexistence of substance use disorder and mental illness, is extremely common. Many individuals struggling with addiction have underlying psychiatric conditions that drive or sustain substance use. Aripiprazole addresses this by:

• Stabilizing MoodReduces the emotional dysregulation that often triggers cravings and relapse.
• Reducing CravingsSome evidence suggests aripiprazole may help reduce cravings for certain substances, particularly in stimulant use disorders.
• Supporting Medication AdherenceLong-acting injectables remove barriers to daily pill-taking and improve treatment engagement in recovery programs.
• Preventing RelapseBy managing underlying psychiatric symptoms, aripiprazole reduces relapse risk and supports sustained recovery.

At Nova Recovery Center, our clinical team uses a comprehensive, integrated approach that addresses both addiction and co-occurring mental health conditions. If aripiprazole or other psychiatric medications are part of your treatment plan, our medical team ensures safe administration, ongoing monitoring, and dose optimization throughout your recovery journey.

Ready to take the next step?

Nova Recovery Center provides inpatient and outpatient drug & alcohol rehab. Call (512) 605-2955 to speak with our team today.